ArticleJournal of clinical medicine2022

Development and Multicenter Validation of a Novel Immune-Inflammation-Based Nomogram to Predict Survival in Western Resectable Gastric and Gastroesophageal Junction Adenocarcinoma (GEA): The NOMOGAST.

Massimiliano Salati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.